Abstract:Background Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) is the most sensitive technique for evaluating gene expression levels. Choosing appropriate reference genes (RGs) is critical for normalizing and evaluating changes in the expression of target genes. However, uniform and reliable RGs for breast cancer research have not been identified, limiting the value of target gene expression studies. Here, we provide a novel approach for mining RGs by using the RNA-seq dataset to identify reliable and accurate RGs that can be applied to different types of breast cancer tissues and cell lines. Methods First, we compiled the transcriptome profiling data from the TCGA database involving 1217 samples to identify novel RGs and then ten genes (SF1, TARDBP, THRAP3, QRICH1, TRA2B, SRSF3, YY1, DNAJC8, RNF10, and RHOA) with relatively stable expression levels were chosen as novel candidate RGs. Additionally, six conventional RGs (ACTB, TUBA1A, RPL13A, B2M, GAPDH, and GUSB) were also selected. To determine and validate the optimal RGs we performed qRT-PCR experiments on 87 samples from 5 types of surgically excised breast tumor specimens including HR+HER2-, HR+HER2+, HR-HER2-, HR-HER2+, breast cancer after neoadjuvant chemotherapy (NAC) and their matched para-carcinoma tissues, furthermore, we also included a benign breast tumor sample. Six biological replicates were included for each tissue. Moreover, we assessed 7 breast cancer cell lines (MCF-10A, MCF-7, T-47D, MDA-MB-231, MDA-MB-468, as well as MDA-MB-231 with either CNR2 knockdown or overexpression; 3 biological replicates for each line). Five statistical algorithms (geNorm, NormFinder, ΔCt method, BestKeeper, and ComprFinder) were used to assess the stability of expression of each RG across all breast cancer tissues and cell lines. Results Our results show that RG combinations SF1+TRA2B+THRAP3 and THRAP3+RHOA+QRICH1 showed stable expression in breast cancer tissues and cell lines, respectively, and that these two combinations displayed good interchangeability. Therefore, we propose that the above two combinations are optimal triplet RGs for breast cancer research. Conclusions In summary, we identified novel and reliable RG combinations for breast cancer research based on a public RNA-seq dataset which lays a solid foundation for accurate normalization of qRT-PCR results across different breast cancer tissues and cells.

RPL13A As a Reference Gene for Normalizing Mrna Transcription of Ovarian Cancer Cells with Paclitaxel and 10-Hydroxycamptothecin Treatments.

Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reaction.

RRM1, TUBB3, TOP2A, CYP19A1, CYP2D6: Difference Between Mrna and Protein Expression in Predicting Prognosis of Breast Cancer Patients

Identification of Valid Reference Genes for the Normalization of RT-qPCR Expression Studies in Human Breast Cancer Cell Lines Treated with and without Transient Transfection

The Use of Laser Microdissection in the Identification of Suitable Reference Genes for Normalization of Quantitative Real-Time PCR in Human FFPE Epithelial Ovarian Tissue Samples.

Identification of Suitable Reference Genes for Measurement of Gene Expression in Human Cervical Tissues.

Tissue-specific Selection of Optimal Reference Genes for Expression Analysis of Anti-Cancer Drug-Related Genes in Tumor Samples Using Quantitative Real-Time RT-PCR.

Selection of Reference Genes for Gene Expression Studies in Human Bladder Cancer Using SYBR-Green Quantitative Polymerase Chain Reaction.

Evaluation and Validation of Suitable Reference Genes for Reverse Transcription-Quantitative Polymerase Chain Reaction Studies in Cholangiocarcinoma Patients and Cell Lines.

Identification of Valid Reference Genes for Mrna and Microrna Normalisation in Prostate Cancer Cell Lines

Platelet RNA Enables Accurate Detection of Ovarian Cancer: an Intercontinental, Biomarker Identification Study.

Identification of Mir-23A As a Novel Microrna Normalizer for Relative Quantification in Human Uterine Cervical Tissues

Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer Via Integrated Bioinformatics Analysis.

Identification of Suitable Reference Genes for Investigating Gene Expression in Human Gallbladder Carcinoma Using Reverse Transcription Quantitative Polymerase Chain Reaction

Identification of suitable reference genes for gene expression studies using quantitative polymerase chain reaction in lung cancer in vitro.

MicroRNA Profile of Paclitaxel-Resistant Serous Ovarian Carcinoma Based on Formalin-Fixed Paraffin-Embedded Samples.

Reference Gene Expression in Human Osteosarcoma Cell Lines Treated by Egb and Ctx

Reference Gene Selection for Real-Time Quantitative PCR Analysis on Ovarian Cryopreservation by Vitrification in Mice

Selecting Optimal Reference Genes for Breast Cancer Research

Identification And Validation Of Reference Genes For Qpcr Detection Of Serum Micrornas In Colorectal Adenocarcinoma Patients

Reference gene evaluation for normalization of gene expression studies with lymph tissue and node‑derived stromal cells of patients with oral squamous cell carcinoma